Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
One of the major problems for the endoscopist during esophagogastroduodenoscopy (EGDS) is the presence of foam, bubbles, mucus and saliva, whether small or large, which can compromise correct endoscopic visibility. Endoscopy of the upper gastrointestinal tract, like that of the lower gastrointestinal tract, requires optimal visualization of the mucosa. It is clear that endoscopic vision is often hindered by the presence of bubbles and foam: multiple aspirations alternating with intraprocedural washes are therefore necessary, which lengthen the time necessary for the endoscopic examination. Nowadays there's no universal raccomandation about a specific preparation before EGDS.
The aim of our study is to compare fasting versus the use of simethicone premedication in combination with N-acetyl- cysteine and acetic acid (LumevisTM).
The study is observational, randomized 1:1, and double blind. Primary outcomes are: grade of mucosa visualization defined by visual analogue scale (0-10) for each analyzed segment (esophagus, stomach and duodenum).
Secondary aims: general patient satisfaction defined by visual analogue scale, eventual adverse events, duration of the exam.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | fasting from solids (6 hours before) and clear fluids (2 hours before the exam) | ||
| Group B | Lumevis intake (50 ml), 30 minutes before the exam plus fasting as group A |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lumevis (IIa class) | Device | intake of Lumevis 30 minutes before EGDS |
|
| Measure | Description | Time Frame |
|---|---|---|
| grade of mucosa visibility | evalueted by VAS after the exam (it will be recorded a video) by a physician that not performed the exam and that are blinded about the randomization | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| general patient satisfaction | evalueted by VAS at the end of the exam, before the discharge to home | 6 months |
| eventual adverse events | evalueted by ASGE lexicon, at the end of the exam, before the discharge to home |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
adult patients who had to perform EGDS
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mauro Manno | Contact | 0039 059659250 | m.manno@ausl.mo.it |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mauro Manno | Recruiting | Carpi | MO | 41012 | Italy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005215 | Fasting |
| ID | Term |
|---|---|
| D005247 | Feeding Behavior |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| duration of the exam | minutes between intubation and extubation of the endoscope from the mouth | 6 months |